Top Related
· CTP. 1 0T 1 3anvfcaH IApeMM1d 0T Pe3epB 0T OLIeHKH 3aK0110BH Pe3epBÞ1 C CT,rJ1aCHO C06CTBeHH _vqpenwre.rreH awr T eKY111a neqaJ16a/3ary 10 B Heptunpežlejl eHa neqa-rlôa Flei10K1)HTa
...(5) (OTM. - AB, 6p. 17 0T 2019 r., B cuna 0T 01.11.2019 r., nonp. - AB, 6p. 20 0T 2019 B Tagu Bpb3Ka, CHI,1TaM, qe He e Hannqe npaBH0 OCHOBaHL'le aa 6bae V13VlCKBaHO npeacTaBfiHeT0
Standard ML / CPN ML
...CTBa MOCKBbl 0T 2 Aeya6pq 2014 r. FIOCTaHOBJ1eHUe IlPaBHTeJ1bCTBa MOCHBbl 0T 11 2013 r. 2.3. 924, 928, 929, 993, 996 1 495 2 110CTaHOBJleHfflO [IPaBHTeJ1bCTBa MOCHBbl 0T 24 MapTa
Monitorização Terapêutica€¦ · FAIXA TERAPÊUTICA Fármaco Faixa terapêutica* Digoxina 0,9-2,0 ng/mL Fenitoína 10-20 mg/L Fenobarbital 15-40 mg/L Gentamicina < 2 mg/L (vale)
FOLDER FIBROSE-CISTICA A4 - NUPAD · Triagem neonatal: • Dosagem da tripsina imunorreativa (TIR) no sangue do recém-nascido. Resultado alterado: • 1ª amostra ≥ 70 ng/ml. Solicitar
ds3asha.educhel.ru · OMC PO 0T 2806.201 Or. Ng 147, reqeHue ceM11 paõoqux AHeVi c MOMeHTa pa60Ty — yueAOMJ1eHue Mm-pauH0HHy10 o Mecre rpa)KA2H, (t'opMa ygeAOM:teHH5 H nop5iAOK
k-avtomatika.ru · 2013 r, 011963 . CPOK neicTBnq AO 13 hi-onq 2023 r. FIpoaneH TIPHKOOM Q)eAepaJ1bHoro arewrcTBa 110 rre,XHnqeCKOMY H MeTPOJ101"HH 0T 13 hi-O'IR 2018 r. Ng 1460 3aMeCTHrreJTb